Earnings Call · Q2 FY2025·2025-07-31

Q2 25EPS +6.67%·Rev n/aQ1 25EPS +60.00%·Rev n/aQ4 24EPS +100.00%*·Rev n/aQ3 24EPS +100.00%*·Rev n/a⚠ consensus missing

Aurinia Pharmaceuticals Inc. AUPH

Joseph M. Miller — Chief Financial Officer

Peter S. Greenleaf — President and Chief Executive Officer

+2.2%1d on move date+2.5% vs SPY3d+26.5%5d+28.3%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AUPH calls or request research access.

More AUPH calls Browse calls Request research access